Revascularization or Optimal Medical Therapy for Stable Ischemic Heart Disease: A Bayesian Meta-Analysis of Contemporary Trials

Cardiovascular Revascularization Medicine - Tập 40 - Trang 42-47 - 2022
Ashish Kumar1, Rajkumar Doshi2, Safi U. Khan3, Mariam Shariff4, Jeswin Baby5,6, Monil Majmundar7, Anmar Kanaa'N8, David P. Hedrick8,9, Rishi Puri9, Grant Reed9, Roxana Mehran10, Samir Kapadia9, Umesh N. Khot9, Ankur Kalra8,9
1Department of Internal Medicine, Cleveland Clinic Akron General, Akron, OH, USA
2Department of Cardiology, St. Joseph's Medical Centre, Paterson, NJ, USA
3Department of Internal Medicine, West Virginia University, Morgantown, WV, USA
4Department of General Surgery, Mayo Clinic, Rochester, MN, USA
5Division of Epidemiology and Biostatistics, St John's Research Institute, Bangalore, India
6Department of Statistical Sciences, Kannur University, Kerala, India
7Department of Internal Medicine, New York Medical College, Metropolitan Hospital Center, NYC, USA
8Heart, Vascular and Thoracic Department, Cleveland Clinic Akron General, Akron, OH, USA
9Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA
10The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Tài liệu tham khảo

Holmes, 2016, Revascularization in stable coronary artery disease: a combined perspective from an interventional cardiologist and a cardiac surgeon, Eur Heart J, 37, 1873, 10.1093/eurheartj/ehw044

Fihn, 2012, Circulation, 126, e354

Kim, 2014, Rate of percutaneous coronary intervention for the management of acute coronary syndromes and stable coronary artery disease in the United States (2007 to 2011), Am J Cardiol, 114, 1003, 10.1016/j.amjcard.2014.07.013

Chan, 2011, Appropriateness of percutaneous coronary intervention, JAMA, 306, 53

Malik, 2020, Potential association of the ISCHEMIA trial with the appropriate use criteria ratings for percutaneous coronary intervention in stable ischemic heart disease, JAMA Intern Med, 180, 1540, 10.1001/jamainternmed.2020.3181

Hachamovitch, 2003, Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography, Circulation, 107, 2900, 10.1161/01.CIR.0000072790.23090.41

Marwick, 2001, Prediction of mortality using dobutamine echocardiography, J Am Coll Cardiol, 37, 754, 10.1016/S0735-1097(00)01191-8

PAL, 2009, Fractional flow reserve versus angiography for guiding percutaneous coronary intervention, N Engl J Med, 360, 213, 10.1056/NEJMoa0807611

Bangalore, 2020, Routine revascularization versus initial medical therapy for stable ischemic heart disease: a systematic review and meta-analysis of randomized trials, Circulation, 142, 841, 10.1161/CIRCULATIONAHA.120.048194

Brophy, 2020, Bayesian interpretation of the EXCEL trial and other randomized clinical trials of left main coronary artery revascularization, JAMA Intern Med, 10.1001/jamainternmed.2020.1647

Spiegelhalter, 1999, Methods in health service research. An introduction to Bayesian methods in health technology assessment, BMJ, 319, 508, 10.1136/bmj.319.7208.508

Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration, BMJ, 339, 10.1136/bmj.b2700

Rao, 2017, Methodological standards for meta-analyses and qualitative systematic reviews of cardiac prevention and treatment studies: a scientific statement from the American Heart Association, Circulation, 136, e172, 10.1161/CIR.0000000000000523

Uman, 2011, Systematic reviews and meta-analyses, J Can Acad Child Adolesc Psychiatry, 20, 57

Sterne, 2019, RoB 2: a revised tool for assessing risk of bias in randomised trials, BMJ, 366

Bürkner, 2017, brms: an R package for Bayesian multilevel models using Stan, J Stat Softw, 1, 10.18637/jss.v080.i01

Carpenter, 2017, Stan: a probabilistic programming language, J Stat Softw, 1, 10.18637/jss.v076.i01

Boden, 2007, Optimal medical therapy with or without PCI for stable coronary disease, N Engl J Med, 356, 1503, 10.1056/NEJMoa070829

Xaplanteris, 2018, Five-year outcomes with PCI guided by fractional flow reserve, N Engl J Med, 379, 250, 10.1056/NEJMoa1803538

2009, A randomized trial of therapies for type 2 diabetes and coronary artery disease, N Engl J Med, 360, 2503, 10.1056/NEJMoa0805796

Maron, 2020, Initial invasive or conservative strategy for stable coronary disease, N Engl J Med, 382, 1395, 10.1056/NEJMoa1915922

Bangalore, 2020, Management of coronary disease in patients with advanced kidney disease, N Engl J Med, 382, 1608, 10.1056/NEJMoa1915925

Hueb, 2004, The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results, J Am Coll Cardiol, 43, 1743, 10.1016/j.jacc.2003.08.065

Nishigaki, 2008, Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease: a randomized, comparative, multicenter study, JACC Cardiovasc Interv, 1, 469, 10.1016/j.jcin.2008.08.002

Bangalore, 2013, Prognostic implications of procedural vs spontaneous myocardial infarction: results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry, Am Heart J, 166, 1027, 10.1016/j.ahj.2013.09.008

Cantor, 2002, Prognostic significance of elevated troponin i after percutaneous coronary intervention, J Am Coll Cardiol, 39, 1738, 10.1016/S0735-1097(02)01877-6

Prasad, 2008, Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention, Circ Cardiovasc Interv, 1, 10, 10.1161/CIRCINTERVENTIONS.108.765610

Werner, 2012, Stroke in patients undergoing coronary angiography and percutaneous coronary intervention: incidence, predictors, outcome and therapeutic options, Expert Rev Cardiovasc Ther, 10, 1297, 10.1586/erc.12.78

Gaudino, 2019, Stroke after coronary artery bypass grafting and percutaneous coronary intervention: incidence, pathogenesis, and outcomes, J Am Heart Assoc, 8, 10.1161/JAHA.119.013032

Madhavan, 2020, Long-term outcomes after revascularization for stable ischemic heart disease, Circ Cardiovasc Interv, 13, 10.1161/CIRCINTERVENTIONS.119.008565

Thông tin
Thông tin xuất bản

Cardiovascular Revascularization Medicine

Tập 40

42-47

Thông tin tác giả